PCOS: Definition & Historical Context

1. What is Polycystic Ovarian Syndrome (PCOS)?

At its core, PCOS is a syndrome, not a disease. A disease typically has a single, well-defined cause. A syndrome, on the other hand, is a collection of signs and symptoms that frequently appear together but for which the underlying cause may be complex and multifactorial.

PCOS is the most common endocrine (hormonal) disorder affecting women of reproductive age.

As the video explained, if we break down the name:

• Poly-: means "many"
• -cystic: refers to "cysts"
• Ovary Syndrome: indicates it's a syndrome affecting the ovaries.

However, the name can be misleading. The "cysts" are not true cysts but rather small, immature follicles that have been arrested in their development. Furthermore, not all women with PCOS have this ovarian appearance, and it is not the root cause of the problem.

The central feature, as stated in the video and confirmed by decades of research, is hyperandrogenism—an excess of androgens (often called "male" hormones, though they are also essential in females). This hormonal imbalance disrupts the normal functioning of the ovaries, leading to the signs and symptoms of PCOS.

2. The Historical Discovery: Stein-Leventhal Syndrome

While PCOS is now widely recognized, its journey to a formal definition was a long one. Early descriptions of women with symptoms we now associate with PCOS date back to the 18th century.

The key historical moment came in 1935 with Irving F. Stein and Michael L. Leventhal. They were the first to formally describe a specific cluster of signs in seven women:

1. Menstrual disturbances (oligomenorrhea or amenorrhea - infrequent or absent periods)
2. Hirsutism (excessive male-pattern hair growth)
3. Enlarged, polycystic-appearing ovaries

For many years, the condition was known as Stein-Leventhal Syndrome.

The initial treatment proposed by Stein and Leventhal was an ovarian wedge resection (surgically removing a piece of the ovary). Because this procedure often restored menstruation and fertility, it led to the belief that the problem was a primary structural defect of the ovary. Consequently, the condition was often called polycystic ovarian disease.

As our understanding deepened, it became clear that the issue was not just a simple "disease" of the ovary but a complex endocrine "syndrome" involving the entire hypothalamic-pituitary-ovarian (HPO) axis and metabolic systems. This shift in terminology from "disease" to "syndrome" reflects a major evolution in medical thinking about PCOS.

3. The Modern Evolution: From Scalpel to Ultrasound and Hormones

After Stein and Leventhal, the focus of research shifted from the physical appearance of the ovaries to the underlying hormonal and functional abnormalities.

This period brought two game-changing advancements:

1. Endocrine Testing: Researchers discovered that women with PCOS often had elevated levels of Luteinizing Hormone (LH) and testosterone. This was a monumental finding, linking the syndrome directly to the HPO axis (which we studied in Module 3) and androgen physiology (Module 5). It proved PCOS was a systemic hormonal disorder.
2. Ultrasound Technology: The development of pelvic ultrasound allowed doctors to visualize the ovaries non-invasively for the first time. This confirmed that many women with the clinical symptoms had ovaries with multiple small follicles, but it also revealed that up to a quarter of healthy women without any symptoms also had this ovarian appearance. This discovery was crucial—it showed that "polycystic ovaries" alone did not equal "polycystic ovarian syndrome."

4. Defining a Syndrome: The Era of Diagnostic Criteria

Because PCOS could present in so many ways (e.g., with or without hirsutism, with or without polycystic-appearing ovaries), the medical community needed a standardized way to diagnose it. This led to the development of formal diagnostic criteria. The evolution of these criteria is the evolution of the modern definition of PCOS.

Let's look at the most significant criteria outlined in the image.

a) The 1990 NIH Criteria

Sponsored by the US National Institutes of Health (NIH), this was the first major consensus. It defined PCOS by the presence of both of the following, after excluding other conditions:

• Hyperandrogenism (clinical or biochemical)
• Chronic anovulation (leading to irregular or absent periods)

Notice that polycystic ovaries on ultrasound were not required for a diagnosis under these criteria. The focus was entirely on the combination of androgen excess and ovulatory dysfunction.

b) The 2003 Rotterdam Criteria

This is the most widely used set of criteria today. A consensus workshop in Rotterdam expanded the definition significantly. To be diagnosed with PCOS under these criteria, a woman must have at least two of the following three features:

1. Hyperandrogenism (clinical or biochemical)
2. Oligo- or anovulation (infrequent or absent ovulation/menstruation)
3. Polycystic Ovarian Morphology (PCOM) on ultrasound

This was a major shift. By adopting a "2 out of 3" rule, the Rotterdam criteria acknowledged that PCOS is a heterogeneous syndrome with different presentations, or phenotypes. For example, a woman with irregular periods and polycystic ovaries but normal androgen levels could now be diagnosed with PCOS.

c) The 2006 Androgen Excess & PCOS Society (AE-PCOS) Criteria

Some experts felt the Rotterdam criteria were too broad. The AE-PCOS Society proposed a more focused definition, insisting that hyperandrogenism was an essential, non-negotiable component. Their criteria required:

• Hyperandrogenism (clinical or biochemical)
• PLUS either Ovarian dysfunction (oligo-anovulation) OR Polycystic ovarian morphology.

This debate between the broader Rotterdam definition and the more androgen-focused AE-PCOS definition highlights the ongoing scientific discussion about the fundamental nature of the syndrome.

Conclusion

In this lesson, we have charted the evolution of PCOS from a vaguely understood condition to a formally defined endocrine syndrome.

Key Takeaways:

• PCOS is a complex and common endocrine syndrome, primarily characterized by hyperandrogenism (androgen excess).
• It was first formally described in 1935 by Stein and Leventhal, who noted a triad of amenorrhea, hirsutism, and enlarged ovaries.
• The understanding of PCOS evolved from a structural "disease" of the ovary to a functional "syndrome" with the discovery of hormonal imbalances (high LH, high testosterone) and the advent of ultrasound.
• The modern definition of PCOS is operationalized through diagnostic criteria, which themselves have evolved. The 1990 NIH criteria required androgen excess and anovulation, while the 2003 Rotterdam criteria broadened the definition to include women with different combinations of symptoms (any 2 of 3: hyperandrogenism, oligo-ovulation, or PCOM).

Preview of the Next Lesson:
Now that we have a solid understanding of what PCOS is and how its definition came to be, our next step is to explore its impact on a global scale. In the next lesson, we will investigate the epidemiology and prevalence of PCOS, asking questions like: How common is it? Does its prevalence vary across different countries and ethnic groups? This will provide the context for why a clear diagnosis is so important.